Let’s assume that the FDA regulators practiced real science without fear or favor in the public interest.
Why would the pharmaceutical industry stocks tank when one of them is forced to exit?
They would presumably be replaced with an equally honest broker who would continue the longstanding practice of honest science in the public interest.
Related: In 2025, WebMD Claims COVID Vax ‘Still Crucial for Children’
Furthermore, why would industry actors describe that fired bureaucrat — who, again, ostensibly regulates their behavior, whose interests are totally unaligned with theirs — as an “ally”?
Via Children’s Health Defense (emphasis added):
Pharma stocks tumbled today after Peter Marks, M.D., Ph.D., director of the agency within the U.S. Food and Drug Administration (FDA) responsible for authorizing vaccines, resigned under pressure from his new…
